Cargando…
Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy
BACKGROUND: Multiple system atrophy (MSA) is a neurodegenerative condition characterized by variable combinations of parkinsonism, autonomic failure, cerebellar ataxia and pyramidal features. Although the distribution of synucleinopathy correlates with the predominant clinical features, the burden o...
Autores principales: | Martinez-Valbuena, Ivan, Visanji, Naomi P., Kim, Ain, Lau, Heather H. C., So, Raphaella W. L., Alshimemeri, Sohaila, Gao, Andrew, Seidman, Michael A., Luquin, Maria R., Watts, Joel C., Lang, Anthony E., Kovacs, Gabor G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819887/ https://www.ncbi.nlm.nih.gov/pubmed/35125105 http://dx.doi.org/10.1186/s40035-022-00283-4 |
Ejemplares similares
-
Disease-Specific α-Synuclein Seeding in Lewy Body Disease and Multiple System Atrophy Are Preserved in Formaldehyde-Fixed Paraffin-Embedded Human Brain
por: Kim, Ain, et al.
Publicado: (2023) -
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
por: Visanji, Naomi P., et al.
Publicado: (2019) -
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
por: Lau, Heather H. C., et al.
Publicado: (2023) -
α-Synuclein Strains Target Distinct Brain Regions and Cell Types
por: Lau, Angus, et al.
Publicado: (2019) -
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)